Trademark Overview
On Thursday, February 12, 2026, a trademark application was filed for CHEMPLUS with the United States Patent and Trademark Office. The USPTO has given the CHEMPLUS trademark a serial number of 99649095. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, June 11, 2026. This trademark is owned by Shenzhen Jingtai Technology Co., Ltd.. The CHEMPLUS trademark is filed in the Machinery Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Blending machines for chemical processing; Dissolving machines for chemical processing; Separating machines for chemical processing; Extracting machines for chemical processing; Conveyors being machines; Stands for machines; Industrial robots; Industrial chemical reactors; Mechanical condensators; Industrial mixer for mixing liquids in the pharmaceutical and chemical industries
Recorded computer operating software; Recorded computer operating system software; Recorded computer software for database management; Downloadable computer programs using artificial intelligence (AI) for use in software development; Downloadable computer software platforms for database management; Downloadable computer software platforms for application development; Programmable logic controllers; Laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; Bio-chips for research or scientific purposes; Laboratory robots; Surveying apparatus and instruments; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Sensor chips for scientific use; Electric sensors
Research and development of new products for others; Scientific laboratory services; Biochemical research and analysis; Research and development services in the field of antibodies; Research and development services of new pharmaceutical products; Research and development services in the field of pharmaceutical preparations; DNA screening for scientific research purposes; Conducting early evaluations in the field of new pharmaceuticals; Testing of pharmaceuticals; Software as a service (SAAS) services featuring software for project management; Software as a service (SAAS) services featuring software for application and database integration; Platform as a service (PAAS) featuring computer software platforms for use in scientific research; Research in the field of artificial intelligence
